Gene · 3817
Papers1,753
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,753
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Transcriptomic Profiles of ESR1 and MMP3 Stratify the Risk of Biochemical Recurrence in Primary Prostate Cancer beyond Clinical Features. | Int J Mol Sci | 2023 | 37176106 | PubTator, text mining | PubMed |
| Potential Role of AGR2 for Mammalian Skin Wound Healing. | Int J Mol Sci | 2023 | 37175601 | PubTator, text mining | PubMed |
| The new era of prostate-specific membrane antigen-directed immunotherapies and beyond in advanced prostate cancer: a review. | Ther Adv Med Oncol | 2023 | 37152424 | PubTator, text mining | PubMed |
| Targeting bromodomain-containing proteins: research advances of drug discovery. | Mol Biomed | 2023 | 37142850 | PubTator, text mining | PubMed |
| Prognostic impact of kallikrein-related peptidase transcript levels in prostate cancer. | Int J Cancer | 2023 | 37139608 | PubTator, text mining | PubMed |
| Epigenetically regulated gene expression profiles decipher four molecular subtypes with prognostic and therapeutic implications in gastric cancer. | Clin Epigenetics | 2023 | 37061743 | PubTator, text mining | PubMed |
| α-Mangostin Promotes In Vitro and In Vivo Degradation of Androgen Receptor and AR-V7 Splice Variant in Prostate Cancer Cells. | Cancers (Basel) | 2023 | 37046780 | PubTator, text mining | PubMed |
| Current Applications of Liquid Biopsy in Gastrointestinal Cancer Disease-From Early Cancer Detection to Individualized Cancer Treatment. | Cancers (Basel) | 2023 | 37046585 | PubTator, text mining | PubMed |
| An integrated in vitro/in silico approach to assess the anti-androgenic potency of isobavachin. | Food Chem Toxicol | 2023 | 37019376 | PubTator, text mining | PubMed |
| Ginsenosides, potential TMPRSS2 inhibitors, a trade-off between the therapeutic combination for anti-PD-1 immunotherapy and the treatment of COVID-19 infection of LUAD patients. | Front Pharmacol | 2023 | 36992839 | PubTator, text mining | PubMed |
| Urinary endogenous peptides as biomarkers for prostate cancer. | Oncol Lett | 2023 | 36970608 | PubTator, text mining | PubMed |
| Exosomes: New regulators of reproductive development. | Mater Today Bio | 2023 | 36969697 | PubTator, text mining | PubMed |
| Prostate cancer bone metastases biology and clinical management (Review). | Oncol Lett | 2023 | 36960185 | PubTator, text mining | PubMed |
| Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer. | Clin Cancer Res | 2023 | 36939530 | PubTator, text mining | PubMed |
| A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytes. | Commun Biol | 2023 | 36934210 | PubTator, text mining | PubMed |
| The androgen-thyroid hormone crosstalk in prostate cancer and the clinical implications. | Eur Thyroid J | 2023 | 36930264 | PubTator, text mining | PubMed |
| One-step endpoint RT-PCR assays for confirmatory body fluid identification. | Forensic Sci Int Genet | 2023 | 36921484 | PubTator, text mining | PubMed |
| Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy. | Clin Cancer Res | 2023 | 36917693 | PubTator, text mining | PubMed |
| Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data. | Radiat Oncol | 2023 | 36906590 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Untargeted Approaches to Reveal Diagnostic Signatures of Male Infertility in Seminal Plasma: A New Laboratory Perspective for the Clinical Management of Infertility? | Int J Mol Sci | 2023 | 36901856 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3817/papers?page=8